Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDIFAST INCMED · Entity 6587 | Former Director | October 06, 2023 | October 30, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDIFAST INC
Report date October 06, 2023 · Filed October 30, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirect(1) | 2,152 |
Reported balance
After 2023-10-06 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-10-06 · Sale · Disposed 5,613 · Balance 2,152 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2023 Filed Oct 30, 2023 16:49 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 5,613 | $73.87 | $414,632.31 |
DisclosureSEC source: 0001645615-23-000004 · primary_doc.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Former Director 10b5-1 filing: No plan indicated Ownership: Indirect · (1) Disclosed balance after: 2,152 Read SEC document |
| May 09, 2023 Filed May 11, 2023 21:42 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 13.342 | $87.50 | $1,167.43 |
DisclosureSEC source: 0001628280-23-017665 · wf-form4_168384131656450.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,590.853 F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:04 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 9.95 | $114.97 | $1,143.95 |
DisclosureSEC source: 0001628280-23-003049 · wf-form4_167599464004476.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,577.51 F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 23:32 UTC | MEDIFAST INC MED · Entity 6587 | PurchaseCommon Stock | 10.537 | $106.93 | $1,126.72 |
DisclosureSEC source: 0001628280-22-029560 · wf-form4_166812310986073.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,892.561 F1 · shares: The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:01 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 8.024 | $138.78 | $1,113.57 |
DisclosureSEC source: 0001104659-22-088735 · tm2223137-2_4seq1.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,882.024 F1 · kind: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock. Read SEC document |
| June 16, 2022 Filed Jun 22, 2022 01:15 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-073168 · tm2219043-2_4seq1.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,874 F1 · shares: Represents the right to receive 1,432 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 16, 2023. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 23:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 542 | $285.09 | $154,518.78 |
DisclosureSEC source: 0001562180-21-004835 · primarydocument.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,442 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 18, 2021. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 00:40 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 679 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-077869 · tm2119051-3_4seq1.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,984 F1 · shares: Represents the right to receive 679 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:30 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionStock Options · Derivative | 2,000 | $0.00 Strike: $27.68 | $0.00 |
DisclosureSEC source: 0001104659-21-032841 · tm218878d1_4.xml · derivative · entry 5 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 2,000 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options vested in three equal annual installments beginning on February 4, 2017. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:30 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionStock Options · Derivative | 2,500 | $0.00 Strike: $28.59 | $0.00 |
DisclosureSEC source: 0001104659-21-032841 · tm218878d1_4.xml · derivative · entry 4 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options vested in three equal annual installments beginning on September 15, 2016. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:30 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 4,500 | $259.02 | $1,165,590.00 |
DisclosureSEC source: 0001104659-21-032841 · tm218878d1_4.xml · nonDerivative · entry 3 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,305 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.631 to $259.440, inclusive. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:30 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 2,000 | $27.68 | $55,360.00 |
DisclosureSEC source: 0001104659-21-032841 · tm218878d1_4.xml · nonDerivative · entry 2 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:30 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 2,500 | $28.59 | $71,475.00 |
DisclosureSEC source: 0001104659-21-032841 · tm218878d1_4.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 21:05 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 535 | $149.25 | $79,848.75 |
DisclosureSEC source: 0001104659-20-081282 · tm2024193d2_4.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,305 F1 · shares: The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on November 19, 2019. Read SEC document |
| June 16, 2020 Filed Jun 19, 2020 00:38 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-074828 · tm2022977d2_4.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,840 F1 · shares: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 00:59 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-010325 · tv514782_4.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,757 F1 · shares: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2020. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:11 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,343 | $153.84 | $206,607.12 |
DisclosureSEC source: 0001144204-18-063208 · tv508565_form4.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,687 F1 · price: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.5529 to $154.2500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 00:27 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 1,343 | $160.12 | $215,041.16 |
DisclosureSEC source: 0001144204-18-059471 · tv507207_4.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,030 Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 23:21 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-007043 · tv485453_form4.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,373 F1 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2019. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:56 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 2,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-010263 · v460101_4.xml · nonDerivative · entry 1 HALLQUIST CONSTANCE J. · CIK 0001645615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,754 F1 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.